Because of these defects and activated phenotypes of T cells in Foxo1-CD4-conditional deficient mice, we have used alternate approach to therapeutically block Foxo1 using Foxo1-siRNA or Foxo1-chemical inhibitor in experimental allergic inflammation model of asthma. This evidence concerns the gene FOXO1 and asthma.